An Open Trial of the Effect of Transdiagnostic Cognitive Behavioural Therapy on Clinical Severity Ratings for Adults with Emotional Disorders
Not Applicable
- Conditions
- Anxiety Disorders,Depressive DisordersObsessive-Compulsive and Related DisordersTrauma and Stress-Related DisordersMental Health - AnxietyMental Health - DepressionMental Health - Other mental health disorders
- Registration Number
- ACTRN12621000486820
- Lead Sponsor
- Cairnmillar Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Adult (18+); DSM-5 principal diagnosis of an anxiety disorder, depressive disorder, obsessive-compulsive disorrder, or post traumatic stress disorder.
Exclusion Criteria
1) Inability to read and communicate in English sufficiently to understand and participate in
assessment and treatment with English-speaking therapists
2) Evidence of dementia or other neurocognitive condition that might interfere with informed consent, or understanding and participating in treatment
3) Evidence of serious suicidality, current alcohol or illicit substance dependence, or any other condition of sufficient severity that requires immediate clinical prioritization.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinician severity ratings (CSR; 0 Absent to 8 Extremely Severe) of the principal diagnosis[week 11 (immediately post-treatment)]
- Secondary Outcome Measures
Name Time Method Depression Anxiety and Stress Scales (DASS-21) Anxiety Scale[Change modelled session-by-session from week 1 to week 12.];World Health Organisation Quality of Life - brief version (WHO-QUL-bref) [Week 11 (immediately post-treatment)];Depression Anxiety and Stress Scales (DASS-21) Depression Scale[Change modelled session-by-session from week 1 to week 12.]